Chelating behavior and biocidal efficiency of tryptophan based mixed-ligand complexes

DNA, the biopolymer as a target material for metalloinsertors: From chemistry to preclinical implications

The coordination of therapeutically interesting designed complexes of stoichiometry [ML(Met)Cl2] [where M=Cu(II), Co(II), Ni(II), Mn(II) and Zn(II), L=benzylidene-4-aminoantipyrine and Met=methionine] has been ascertained on the basis of physicochemical techniques. Their interaction with CT DNA reveals that they are good intercalators. The anticancer mechanism of our complexes is documented from their enhanced DNA splitting personalities under physiological conditions. To reveal the chemotherapeutic action of these complexes, we explored the inflammatory response, analgesic and antioxidant activities. Moreover, all the complexes show good antimicrobial activity against few bacterial and fungal strains. Our study has identified the mechanism of action of these complexes on inhibiting tumor cells and suggested that they have great potential as novel anticancer agents.

Investigation of in vitro anticancer and DNA strap interactions in live cells using carboplatin type Cu(II) and Zn(II) metalloinsertors

A series of carboplatin type Cu(II) and Zn(II) metalloinsertors (1-8) having β-diketone analogues and biologically significant cyclobutane-1,1-dicarboxylic acid have been synthesized and characterized by spectral and analytical methods. The binding and cleavage propensity of these metalloinsertors on DNA and their cytotoxic effects in live cells have been explored. From the gel electrophoresis study, it is observed that the complexes 1-8 cleave pBR322 DNA via a hydrolytic mechanism induced by hydroxyl radical scavengers, DMSO and EtOH as the reactive oxygen species (ROS). In vivo antitumor efficacy has been studied on EAC tumor bearing mice which is assessed by mean survival time, effect on hematological parameters and solid tumor volume. The results strongly support that complex 1 shows potent antitumor effect against EAC and higher than the standard drug carboplatin. Moreover, the cytotoxicity of the complexes, screened on a panel of human cancerous cell lines viz., human cervical cancer cells (HeLa), human breast adenocarcinoma cells (MCF-7), human laryngeal epithelial carcinoma cells (HEp-2), human liver carcinoma cells (Hep G2) and non-cancerous NIH 3T3 mouse embryonic fibroblasts cell lines, reveals that complex 1 exhibits a better anticancer activity than other complexes and standards.

Influence of electron beam irradiation on spectral, thermal, morphological and catalytic properties of Co(II) complex immobilized on chitosan's Schiff base

This study was carried out to investigate the effect of electron beam irradiation on the spectral and catalytic properties of chitosan supported (ONClCl) tetra coordinated Co(II) complex, [Co(OIAC)Cl2]. The complex was subjected to electron beam irradiation of 100 Gy, 1 kGy and 10 kGy doses. Chain scission of chitosan was observed on irradiation at 100 Gy and 10 kGy and chain linking at 1 kGy as evidenced by viscosity and FT-IR spectroscopic studies. This observation was also confirmed by thermo gravimetric and differential thermogravimetric (TG-DTG) analysis. It revealed that the thermal stability of the complex was increased at 1 kGy irradiation and decreased at 100 Gy and 10 kGy. In addition, the effect of electron beam irradiation on the surface morphology of the complex was studied by scanning electron microscopy. Catalytic abilities of both non-irradiated complex and irradiated complexes were determined and compared in the cyclohexane oxidation using hydrogen peroxide oxidant. The catalytic activity was found to increase after irradiation at all doses. Though the complex irradiated at 10 kGy showed highest conversion efficiency, irradiation at 1 kGy is suggested as the best dose due to the extensive reusability and adequate catalytic ability of the complex.